1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Companion Animal Pharmaceuticals Market Outlook
4.1.
Market Size &
Forecast
4.1.1.
By Value
4.2.
Market Share & Forecast
4.2.1. By Indication
(Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases,
Behavioral Diseases, Other)
4.2.2. By Animal (Dogs,
Cats, Horses, Other)
4.2.3. By Distribution
Channel (Veterinary Hospitals and Clinics, Retail Pharmacies, Others)
4.2.4.
By Region
4.2.5.
By Company (2023)
4.3.
Market Map
4.3.1.
By Indication
4.3.2.
By Animal
4.3.3.
By Distribution
Channel
4.3.4.
By Region
5. Asia Pacific Companion Animal Pharmaceuticals Market
Outlook
5.1.
Market Size &
Forecast
5.1.1.
By Value
5.2.
Market Share &
Forecast
5.2.1.
By Indication
5.2.2. By Animal
5.2.3. By Distribution
Channel
5.2.4.
By Country
5.3.
Asia Pacific:
Country Analysis
5.3.1.
China Companion
Animal Pharmaceuticals Market Outlook
5.3.1.1.
Market Size & Forecast
5.3.1.1.1.
By Value
5.3.1.2.
Market Share & Forecast
5.3.1.2.1.
By Indication
5.3.1.2.2.
By Animal
5.3.1.2.3.
By Distribution
Channel
5.3.2.
India Companion
Animal Pharmaceuticals Market Outlook
5.3.2.1.
Market Size & Forecast
5.3.2.1.1.
By Value
5.3.2.2.
Market Share & Forecast
5.3.2.2.1.
By Indication
5.3.2.2.2.
By Animal
5.3.2.2.3.
By Distribution
Channel
5.3.3.
Australia Companion
Animal Pharmaceuticals Market Outlook
5.3.3.1.
Market Size & Forecast
5.3.3.1.1.
By Value
5.3.3.2.
Market Share & Forecast
5.3.3.2.1.
By Indication
5.3.3.2.2.
By Animal
5.3.3.2.3.
By Distribution
Channel
5.3.4.
Japan Companion
Animal Pharmaceuticals Market Outlook
5.3.4.1.
Market Size & Forecast
5.3.4.1.1.
By Value
5.3.4.2.
Market Share & Forecast
5.3.4.2.1.
By Indication
5.3.4.2.2.
By Animal
5.3.4.2.3.
By Distribution
Channel
5.3.5.
South Korea
Companion Animal Pharmaceuticals Market Outlook
5.3.5.1.
Market Size & Forecast
5.3.5.1.1.
By Value
5.3.5.2.
Market Share & Forecast
5.3.5.2.1.
By Indication
5.3.5.2.2.
By Animal
5.3.5.2.3.
By Distribution
Channel
6. Europe Companion Animal Pharmaceuticals Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1. By Indication
6.2.2. By Animal
6.2.3. By Distribution
Channel
6.2.4. By Country
6.3.
Europe: Country
Analysis
6.3.1.
France Companion
Animal Pharmaceuticals Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Indication
6.3.1.2.2.
By Animal
6.3.1.2.3.
By Distribution
Channel
6.3.2.
Germany Companion
Animal Pharmaceuticals Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Indication
6.3.2.2.2.
By Animal
6.3.2.2.3.
By Distribution
Channel
6.3.3.
Spain Companion
Animal Pharmaceuticals Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Indication
6.3.3.2.2.
By Animal
6.3.3.2.3.
By Distribution
Channel
6.3.4.
Italy Companion
Animal Pharmaceuticals Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Indication
6.3.4.2.2.
By Animal
6.3.4.2.3.
By Distribution
Channel
6.3.5.
United Kingdom
Companion Animal Pharmaceuticals Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Indication
6.3.5.2.2.
By Animal
6.3.5.2.3.
By Distribution
Channel
7. North America Companion Animal Pharmaceuticals Market
Outlook
7.1.
Market Size &
Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By Indication
7.2.2. By Animal
7.2.3. By Distribution
Channel
7.2.4.
By Country
7.3.
North America:
Country Analysis
7.3.1.
United States
Companion Animal Pharmaceuticals Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Indication
7.3.1.2.2.
By Animal
7.3.1.2.3.
By Distribution
Channel
7.3.2.
Mexico Companion
Animal Pharmaceuticals Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Indication
7.3.2.2.2.
By Animal
7.3.2.2.3.
By Distribution
Channel
7.3.3.
Canada Companion
Animal Pharmaceuticals Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Indication
7.3.3.2.2.
By Animal
7.3.3.2.3.
By Distribution
Channel
8. South America Companion Animal Pharmaceuticals Market
Outlook
8.1.
Market Size &
Forecast
8.1.1.
By Value
8.2.
Market Share &
Forecast
8.2.1. By Indication
8.2.2. By Animal
8.2.3. By Distribution
Channel
8.2.4.
By Country
8.3.
South America:
Country Analysis
8.3.1.
Brazil Companion
Animal Pharmaceuticals Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Indication
8.3.1.2.2.
By Animal
8.3.1.2.3.
By Distribution
Channel
8.3.2.
Argentina Companion
Animal Pharmaceuticals Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Indication
8.3.2.2.2.
By Animal
8.3.2.2.3.
By Distribution
Channel
8.3.3.
Colombia Companion
Animal Pharmaceuticals Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Indication
8.3.3.2.2.
By Animal
8.3.3.2.3.
By Distribution
Channel
9. Middle East and Africa Companion Animal Pharmaceuticals
Market Outlook
9.1.
Market Size &
Forecast
9.1.1.
By Value
9.2.
Market Share &
Forecast
9.2.1. By Indication
9.2.2. By Animal
9.2.3. By Distribution
Channel
9.2.4.
By Country
9.3.
MEA: Country Analysis
9.3.1.
South Africa
Companion Animal Pharmaceuticals Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Indication
9.3.1.2.2.
By Animal
9.3.1.2.3.
By Distribution
Channel
9.3.2.
Saudi Arabia
Companion Animal Pharmaceuticals Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Indication
9.3.2.2.2.
By Animal
9.3.2.2.3.
By Distribution
Channel
9.3.3.
UAE Companion Animal
Pharmaceuticals Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Indication
9.3.3.2.2.
By Animal
9.3.3.2.3.
By Distribution
Channel
10.
Market Dynamics
10.1.
Drivers
10.2.
Challenges
11.
Market Trends &
Developments
11.1.
Recent Developments
11.2.
Product Launches
11.3.
Mergers &
Acquisitions
12.
Global Companion
Animal Pharmaceuticals Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Product
14.
Competitive
Landscape
14.1. Zoetis Services LLC
14.1.1. Business Overview
14.1.2.
Company Snapshot
14.1.3.
Product &
Services
14.1.4. Financials (In case
of listed)
14.1.5.
Recent Developments
14.1.6.
SWOT Analysis
14.2. Merck & Co.,
Inc.
14.3. Boehringer Ingelheim International GmbH
14.4. Elanco Animal Health
Incorporated
14.5. Virbac Taiwan Co., Ltd.
14.6. Vetoquinol
S.A.
14.7. Dechra
Pharmaceuticals Limited
14.8. Chanelle Pharma
14.9. KyoritsuSeiyaku Corp
15.
Strategic Recommendations
16.
About Us & Disclaimer